litlas
ログインアカウント作成

Kim Margolin

1985–2025 年に発表

118
論文数
30,075
被引用数
82
h 指数
113
i10 指数

被引用数

Kim Margolin の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 1 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 4 件1990 年: 被引用 8 件1991 年: 被引用 17 件1992 年: 被引用 20 件1993 年: 被引用 38 件1994 年: 被引用 14 件1995 年: 被引用 21 件1996 年: 被引用 10 件1997 年: 被引用 20 件1998 年: 被引用 22 件1999 年: 被引用 16 件2000 年: 被引用 23 件2001 年: 被引用 36 件2002 年: 被引用 83 件2003 年: 被引用 75 件2004 年: 被引用 99 件2005 年: 被引用 74 件2006 年: 被引用 98 件2007 年: 被引用 151 件2008 年: 被引用 131 件2009 年: 被引用 171 件2010 年: 被引用 153 件2011 年: 被引用 140 件2012 年: 被引用 156 件2013 年: 被引用 155 件2014 年: 被引用 162 件2015 年: 被引用 272 件2016 年: 被引用 427 件2017 年: 被引用 461 件2018 年: 被引用 392 件2019 年: 被引用 1,143 件2020 年: 被引用 1,216 件2021 年: 被引用 1,095 件2022 年: 被引用 802 件2023 年: 被引用 660 件2024 年: 被引用 1,035 件2025 年: 被引用 503 件2026 年: 被引用 15 件1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,265 件、この内訳の 30.9%中国: 引用元論文 1,200 件、この内訳の 8.7%ドイツ: 引用元論文 779 件、この内訳の 5.7%イタリア: 引用元論文 759 件、この内訳の 5.5%イギリス: 引用元論文 687 件、この内訳の 5%フランス: 引用元論文 650 件、この内訳の 4.7%オーストラリア: 引用元論文 489 件、この内訳の 3.5%オランダ: 引用元論文 476 件、この内訳の 3.5%カナダ: 引用元論文 447 件、この内訳の 3.2%スペイン: 引用元論文 430 件、この内訳の 3.1%スイス: 引用元論文 375 件、この内訳の 2.7%日本: 引用元論文 286 件、この内訳の 2.1%
0%30.9%その他 21.4%

機関

分野

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Immunology and Microbiology12%
  • Engineering1.1%
  • Neuroscience0.6%
  • Materials Science0.3%
  • その他1.6%

トピック

  • Cancer Immunotherapy and Biomarkers13.6%
  • Immunotherapy and Immune Responses8.2%
  • CAR-T cell therapy research6.5%
  • Brain Metastases and Treatment3.6%
  • Immune Cell Function and Interaction3.4%
  • Melanoma and MAPK Pathways3.2%
  • その他61.5%

共著者

全論文

検索で開く
  1. Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

    著者: Sapna P. Patel, Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom, Siwen Hu‐Lieskovan, Christopher D. Lao, Leslie A. Fecher, Thach‐Giao Truong, Jennifer L. Eisenstein, Sunandana Chandra, Jeffrey A. Sosman, Kari Kendra, Richard C. Wu, Craig Devoe, Gary B. Deutsch, Aparna Hegde, Maya Khalil, Ankit Mangla, Amy M. Reese, Merrick I. Ross, Andrew Poklepovic, Giao Q. Phan, Adedayo A. Onitilo, Demet G. Yasar, Benjamin Powers, Gary C. Doolittle, Gino K. In, Niels Kokot, Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James Warneke, Alexandra P. Ikeguchi, Jose Eugenio Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy C. Hsueh, Kim Margolin, Warren Chow, Kenneth F. Grossmann, Eliana Dietrich, Víctor G. Prieto, Michael Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa A. Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas - New England Journal of Medicine 2023 被引用: 827

  2. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

    著者: Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski, Ramaswamy Govindan, Aung Naing, Nina Bhardwaj, Kim Margolin, Mark M. Awad, Matthew D. Hellmann, Jessica J. Lin, Terence W. Friedlander, Meghan E. Bushway, Kristen N. Balogh, Tracey Sciuto, Victoria Kohler, Samantha Jane Turnbull, Rana H. Besada, Riley R. Curran, Benjamin Trapp, Julian Scherer, Asaf Poran, Dewi Harjanto, Dominik Barthelme, Ying S. Ting, Jesse Z. Dong, Yvonne Ware, Yu-Ting Huang, Zhengping Huang, Amy Wanamaker, Lisa D. Cleary, Melissa A. Moles, Kelledy Manson, Joel Greshock, Zakaria Khondker, Ed Fritsch, Michael S. Rooney, Mark DeMario, Richard B. Gaynor, Lakshmi Srinivasan - Cell 2020 被引用: 763

  3. Response assessment criteria for brain metastases: proposal from the RANO group

    著者: Nancy U. Lin, Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Daniel P. Barboriak, Brigitta G. Baumert, Martin Bendszus, Paul D. Brown, D. Ross Camidge, Susan M. Chang, Janet Dancey, Elisabeth G.E. de Vries, Laurie E. Gaspar, Gordon J. Harris, F. Stephen Hodi, Steven N. Kalkanis, Mark E. Linskey, David Macdonald, Kim Margolin, Minesh P. Mehta, David Schiff, Riccardo Soffietti, John H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen - The Lancet Oncology 2015 被引用: 1,088

  4. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

    著者: Dirk Schadendorf, F. Stephen Hodi, Caroline Robert, Jeffrey S. Weber, Kim Margolin, Omid Hamid, Debra A. Patt, Tai‐Tsang Chen, David M. Berman, Jedd D. Wolchok - Journal of Clinical Oncology 2015 被引用: 2,122

  5. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

    著者: Hussein A. Tawbi, Peter Forsyth, Alain P. Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos, Nikhil I. Khushalani, Karl D. Lewis, Christopher D. Lao, Michael A. Postow, Michael B. Atkins, Marc S. Ernstoff, David A. Reardon, Igor Puzanov, Ragini R. Kudchadkar, Reena Thomas, Ahmad A. Tarhini, Anna C. Pavlick, Joel Jiang, Alexandre Avila, Sheena Demelo, Kim Margolin - New England Journal of Medicine 2018 被引用: 1,321

  6. Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

    著者: Ari M. Vanderwalde, Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia, Lawrence F. Kuklinski, Frances A. Collichio, Jeffrey A. Sosman, Alexandra P. Ikeguchi, Adrienne I. Victor, Thach‐Giao Truong, Bartosz Chmielowski, David C. Portnoy, Yuanbin Chen, Kim Margolin, Charles Bane, Constantin A Dasanu, Douglas B. Johnson, Zeynep Eroglu, Sunandana Chandra, Egmidio Medina, Cynthia R. Gonzalez, Ignacio Baselga-Carretero, Agustin Vega-Crespo, Ivan Perez Garcilazo, Elad Sharon, Siwen Hu‐Lieskovan, Sapna P. Patel, Kenneth F. Grossmann, James Moon, Michael C. Wu, Antoni Ribas - Nature Medicine 2023 被引用: 167

  7. High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

    著者: Michael B. Atkins, Michael T. Lotze, Janice P. Dutcher, Richard I. Fisher, Geoffrey R. Weiss, Kim Margolin, Jeff Abrams, Mario Sznol, David Parkinson, Michael Hawkins, Carolyn Paradise, Lori Kunkel, Steven A. Rosenberg - Journal of Clinical Oncology 1999 被引用: 2,034

  8. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie Miller, Lakshmanan Annamalai, Sneha Berry, Elliot Chartash, Adil Daud, Steven P. Fling, Philip Friedlander, Harriet M. Kluger, Holbrook E. Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M. Pardoll, Sunil Reddy, Erica Shantha, William H. Sharfman, Elad Sharon, Lynn Shemanski, Michi M. Shinohara, Joel Sunshine, Janis M. Taube, John A. Thompson, Steven M. Townson, Jennifer H. Yearley, Suzanne L. Topalian, Martin A. Cheever - New England Journal of Medicine 2016 被引用: 1,243

  9. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

    著者: Antoni Ribas, Igor Puzanov, Reinhard Dummer, Dirk Schadendorf, Omid Hamid, Caroline Robert, F. Stephen Hodi, Jacob Schachter, Anna C. Pavlick, Karl D. Lewis, Lee D. Cranmer, Christian U. Blank, Steven O’Day, Paolo A. Ascierto, April K.S. Salama, Kim Margolin, Carmen Loquai, Thomas Eigentler, Tara C. Gangadhar, Matteo S. Carlino, Sanjiv S. Agarwala, Stergios J. Moschos, Jeffrey A. Sosman, Simone M. Goldinger, Ronnie Shapira‐Frommer, René González, John M. Kirkwood, Jedd D. Wolchok, Alexander M.M. Eggermont, Xiaoyun Li, Wei Zhou, Adriane M Zernhelt, Joy Lis, Scot Ebbinghaus, Sunyu Kang, Adil Daud - The Lancet Oncology 2015 被引用: 1,564

  10. Cytokines in Cancer Immunotherapy

    著者: Sylvia Lee, Kim Margolin - Cancers 2011 被引用: 683

  11. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

    著者: Susan M. Swetter, John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Genevieve M. Boland, Bartosz Chmielowski, Dominick J. DiMaio, Alison B. Durham, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Brian Gastman, Kenneth F. Grossmann, Samantha Guild, Ashley M. Holder, Douglas B. Johnson, Richard W. Joseph, Giorgos C. Karakousis, Kari Kendra, Julie R. Lange, Ryan M. Lanning, Kim Margolin, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, April K.S. Salama, Rohit Sharma, Joseph J. Skitzki, Jeffrey A. Sosman, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2021 被引用: 337

  12. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

    著者: Robert J. Motzer, Brian I. Rini, David F. McDermott, Bruce G. Redman, Timothy M. Kuzel, Michael R. Harrison, Ulka N. Vaishampayan, Harry A. Drabkin, Saby George, Theodore F. Logan, Kim Margolin, Elizabeth R. Plimack, Alexandre Lambert, Ian M. Waxman, Hans J. Hammers - Journal of Clinical Oncology 2014 被引用: 1,078

  13. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

    著者: Kim Margolin, Marc S. Ernstoff, Omid Hamid, Donald P. Lawrence, David F. McDermott, Igor Puzanov, Jedd D. Wolchok, Joseph I. Clark, Mario Sznol, Theodore F. Logan, Jon Richards, Tracy Michener, Ágnes Balogh, Kevin N. Heller, F. Stephen Hodi - The Lancet Oncology 2012 被引用: 1,081

  14. Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Phillip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Reddy, Brian C. Boulmay, Adam I. Riker, Melissa Burgess, Brent A. Hanks, Thomas Olencki, Kim Margolin, Lisa Lundgren, Abha Soni, Nirasha Ramchurren, Candice D. Church, Song Y. Park, Michi M. Shinohara, Bob Salim, Janis M. Taube, Steven Bird, Nageatte Ibrahim, Steven P. Fling, Blanca Homet Moreno, Elad Sharon, Martin A. Cheever, Suzanne L. Topalian - Journal of Clinical Oncology 2019 被引用: 390

  15. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    著者: Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett Carter, Adil Daud, Mark B. Faries, Leslie A. Fecher, Keith T. Flaherty, Jeffrey E. Gershenwald, Omid Hamid, Angela Hong, John M. Kirkwood, Serigne Lo, Kim Margolin, Jane L. Messina, Michael A. Postow, Helen Rizos, Merrick I Ross, Elisa A. Rozeman, Robyn P.M. Saw, Vernon K. Sondak, Ryan J. Sullivan, Janis M. Taube, John F. Thompson, Bart A. van de Wiel, Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 被引用: 218

  16. Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors

    著者: Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, Jeffrey S. Miller, Sylvia M. Lee, Ann W. Silk, Shernan G. Holtan, Andreanne M. Lacroix, Steven P. Fling, Judith C. Kaiser, Jack O. Egan, Monica Jones, Peter R. Rhode, Amy D. Rock, Martin A. Cheever, Hing C. Wong, Marc S. Ernstoff - Clinical Cancer Research 2018 被引用: 206

  17. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

    著者: Pavlina Chuntova, Frances Chow, Payal Watchmaker, Mildred Galvez, Amy B. Heimberger, Evan W. Newell, Aarón Díaz, Ronald A. DePinho, Ming O. Li, E. John Wherry, Duane A. Mitchell, Masaki Terabe, Derek A. Wainwright, Jay A. Berzofsky, Christel Herold‐Mende, James R. Heath, Michael Lim, Kim Margolin, E. Antonio Chiocca, Noriyuki Kasahara, Benjamin M. Ellingson, Christine E. Brown, Yvonne Chen, Peter E. Fecci, David A. Reardon, Gavin P. Dunn, Linda M. Liau, J Costello, Wolfgang Wick, Timothy F. Cloughesy, William C. Timmer, Patrick Y. Wen, Robert M. Prins, Michael Platten, Hideho Okada - Neuro-Oncology 2020 被引用: 93

  18. Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).

    著者: Anthony B. El-Khoueiry, Marwan Fakih, Michael S. Gordon, Apostolia M. Tsimberidou, Andrea J. Bullock, Breelyn A. Wilky, Jonathan C. Trent, Kim Margolin, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Bruno Bockorny, Justin C. Moser, Joseph E. Grossman, W.I. Ortuzar Feliu, Katherine Rosenthal, Steven O’Day, Heinz‐Josef Lenz, Benjamin L. Schlechter - Journal of Clinical Oncology 2023 被引用: 55

  19. National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities

    著者: Michelle M. Kim, Minesh P. Mehta, Dee Dee Smart, Patricia S. Steeg, Julie A. Hong, Michael Graham Espey, Pataje G.S. Prasanna, Laura Crandon, Christine Hodgdon, Niki Kozak, Terri S. Armstrong, Aki Morikawa, Nicole E. Willmarth, Kirk Tanner, Adrienne Boire, Melanie Hayden Gephart, Kim Margolin, Jona A. Hattangadi‐Gluth, Hussein A. Tawbi, Daniel M. Trifiletti, Caroline Chung, Upal Basu-Roy, Robyn Burns, Isabella C. Glitza Oliva, Ayal A. Aizer, Carey K. Anders, Joanne Davis, Manmeet S. Ahluwalia, Veronica Chiang, Jing Li, Rupesh Kotecha, Silvia C. Formenti, Benjamin M. Ellingson, Vinai Gondi, Paul W. Sperduto, Jill S. Barnholtz‐Sloan, Jordi Rodón, Eudocia Q. Lee, Mustafa Khasraw, D.N. Yeboa, Priscilla K. Brastianos, Evanthia Galanis, C. Norman Coleman, Mansoor M. Ahmed - The Lancet Oncology 2023 被引用: 39

  20. Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

    著者: David F. McDermott, Meredith M. Regan, Joseph I. Clark, Lawrence E. Flaherty, Geoffrey R. Weiss, Theodore F. Logan, John M. Kirkwood, Michael S. Gordon, Jeffrey A. Sosman, Marc S. Ernstoff, Christopher Tretter, Walter J. Urba, John W. Smith, Kim Margolin, James W. Mier, Jared Gollob, Janice P. Dutcher, Michael B. Atkins - Journal of Clinical Oncology 2004 被引用: 819

  21. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

    著者: Hussein A. Tawbi, Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Thomas, John A. Glaspy, Sekwon Jang, Alain P. Algazi, Nikhil I. Khushalani, Michael A. Postow, Anna C. Pavlick, Marc S. Ernstoff, David A. Reardon, Igor Puzanov, Ragini R. Kudchadkar, Ahmad A. Tarhini, Anne Sumbul, Jasmine I. Rizzo, Kim Margolin - Neuro-Oncology 2021 被引用: 125

  22. Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

    著者: Grant A. McArthur, Michele Maio, Ana Arance, Paul Nathan, Christian U. Blank, Marie‐Françoise Avril, Claus Garbe, Axel Hauschild, Dirk Schadendorf, Omid Hamid, Michael Fluck, Melissa S. Thebeau, Jacob Schachter, Richard Kefford, Marc C. Chamberlain, Martina Makrutzki, Susan Robson, René González, Kim Margolin - Annals of Oncology 2016 被引用: 246

  23. Updates in the management of brain metastases

    著者: Nils D. Arvold, Eudocia Q. Lee, Minesh P. Mehta, Kim Margolin, Brian M. Alexander, Nancy U. Lin, Carey K. Anders, Riccardo Soffietti, D. Ross Camidge, Michael A. Vogelbaum, Ian F. Dunn, Patrick Y. Wen - Neuro-Oncology 2016 被引用: 284

  24. Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study

    著者: Brendan D. Curti, Jon Richards, John Hyngstrom, Gregory A. Daniels, Mark B. Faries, Lynn G. Feun, Kim Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang, Anlong Li, Robert H.I. Andtbacka - Journal for ImmunoTherapy of Cancer 2022 被引用: 29